| Combination Chemotherapy Compared With Mitoxantrone in Treating Older Patients With Advanced Breast Cancer (NCT00002498) | Leiden University Medical Center | 1992-07-01 |
| Genetic Studies in Breast Cancer (NCT00582322) | Memorial Sloan Kettering Cancer Center | 1992-02-01 |
| Comparison of Four Different Treatment Regimens in Treating Women With Stage I Breast Cancer (NCT00006030) | British Association of Surgical Oncology: Breast Group | 1992-01-01 |
| High-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Hematologic Cancer or Solid Tumors (NCT00060255) | Roswell Park Cancer Institute | 1991-12-01 |
| High-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Poor-Prognosis Breast Cancer (NCT00002509) | Temple University | 1991-11-01 |
| Tamoxifen in Treating Women With Breast Cancer (NCT00003678) | University Hospital Birmingham | 1991-05-01 |
| Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer (NCT00002475) | St. Vincent Medical Center - Los Angeles | 1991-04-01 |
| Women At Risk: The High Risk Breast Cancer Program (NCT01034891) | New York Presbyterian Hospital | 1991-01-01 |
| Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer (NCT00002520) | Eastern Cooperative Oncology Group | 1990-12-07 |
| The French E3N Prospective Cohort Study (NCT03285230) | Institut National de la Santé Et de la Recherche Médicale, France | 1990-06-15 |
| Bergonie Institute Breast Cancer Database (NCT02893761) | Institut Bergonié | 1990-01-01 |
| High Risk Breast Clinic: Protocol for Women at Increased Risk for Developing Breast Cancer (NCT00291096) | Carol Fabian, MD | 1989-08-01 |
| Combination Chemotherapy (FLAC) Combined With Granulocyte-Macrophage Colony Stimulating Factor in Locally Advanced and Metastatic Breast Cancer (NCT00001239) | National Cancer Institute (NCI) | 1989-07-01 |
| SWOG-8814 Tamoxifen With or Without Combination Chemotherapy in Postmenopausal Women Who Have Undergone Surgery for Breast Cancer (NCT00929591) | SWOG Cancer Research Network | 1989-05-01 |
| Randomized Boost Versus no Boost Irradiation of Early Breast Cancer (NCT02295033) | European Organisation for Research and Treatment of Cancer - EORTC | 1989-05-01 |
| Safety of Omitting Axillary Surgery in Breast Cancer Patients With Isolated Chest Wall Recurrence (NCT06088719) | KK Women's and Children's Hospital | 1989-01-01 |
| Diet and Breast Cancer Prevention Trial (NCT00148057) | University Health Network, Toronto | 1988-01-01 |
| High-Dose Megestrol in Treating Patients With Metastatic Breast Cancer, Endometrial Cancer, or Mesothelioma (NCT00002465) | St. Vincent Medical Center - Los Angeles | 1987-12-01 |
| Adjuvant Hormone Therapy in Treating Women With Operable Breast Cancer (NCT00002460) | Cancer Research UK | 1987-09-01 |
| Examining the Long-Term Risks of Oophorectomy (NCT00655447) | Parker, William H., M.D. | 1980-01-01 |
| The Treatment of Stage I and II Carcinoma of the Breast With Mastectomy and Axillary Dissection Versus Excisional Biopsy, Axillary Dissection, and Definitive Irradiation (NCT01468883) | National Cancer Institute (NCI) | 1979-09-04 |
| Prognostic and Predictive Factors for Small Breast Tumors (NCT03390608) | Karolinska Institutet | 1977-01-01 |
| Immunotherapy After Surgery in Treating Patients With Breast Cancer, Colon Cancer, or Melanoma (NCT00002455) | Centro Oncologico de Excelencia | 1971-04-01 |
| Low Level Laser Therapy for Hair Preservation With Chemotherapy for Breast Cancer (NCT01081106) | Northwestern University | |
| An Open-Label, Expanded Access Protocol of Iniparib Breast Cancer (NCT01130259) | Sanofi | |
| Comparison of Biomarkers Based on Fine-Needle Aspiration in Women at Increased or Normal Risk of Breast Cancer (NCT00041353) | Fox Chase Cancer Center | |
| CP-751871 In Treating Women With Early-Stage Breast Cancer That Can Be Removed By Surgery (NCT00635245) | Pfizer | |
| Managed Access Programs for LEE011, Ribociclib (NCT05038631) | Novartis Pharmaceuticals | |
| Breast Cancer Registry - National University Health System, Singapore (NCT01247441) | National University Hospital, Singapore | |
| Docetaxel and St. John's Wort in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery (NCT00041171) | Alliance for Clinical Trials in Oncology | |
| Partial-Breast Radiation Therapy in Treating Women With Early-Stage Breast Cancer (NCT01008514) | Ohio State University Comprehensive Cancer Center | |
| Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients (NCT05974410) | AVM Biotechnology Inc | |
| UFT/LV Maintenance Vs Observation in Metastatic Breast Cancer Responsive to Chemotherapy (NCT00189631) | Association Européenne de Recherche en Oncologie | |
| Expanded Access for the Treatment of Cancers With Rearranged During Transfection (RET) Activation (NCT03906331) | Eli Lilly and Company | |
| Managed Access Programs for BYL719, Alpelisib (NCT04085653) | Novartis Pharmaceuticals | |
| An Expanded Access Program for AM0010 (Pegilodecakin) (NCT03554434) | Eli Lilly and Company | |
| S0348 Vaccine Therapy in Treating Patients With Stage IIIB or Stage IV Breast Cancer in Remission (NCT00227474) | SWOG Cancer Research Network | |
| Standardization Research of TCM Syndrome Differentiation and Treatment on Advanced Breast Cancer (NCT02011880) | Shanghai University of Traditional Chinese Medicine | |
| Protection of Ovarian Function With Goserelin Acetate in Premenopausal Early Breast Cancer Patients With Chemotherapy (NCT00888082) | AstraZeneca | |
| Early Access Program Providing HER2/HER3 Bispecific Antibody, MCLA-128, for a Patient With Advanced NRG1-Fusion Positive Solid Tumor (NCT04100694) | Merus B.V. | |
| Do Community Cancer Support Groups Reduce Physiological Stress in Women With Primary Breast Cancer? (NCT00186524) | Stanford University | |
| Tumour Necrosis Factor Release in Locally Advanced Breast Cancer Patients Receiving Neoadjuvant Docetaxel (NCT01539876) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | |
| Lymphatic Mapping After Previous Breast Surgery (NCT01164748) | Catharina Ziekenhuis Eindhoven | |
| Study of 111In-DAC as a Medical Imaging Agent for the Detection of Breast Cancer (NCT00040430) | Copharos | |
| Studying Biological Markers of Fatigue in Women With Residual Invasive Breast Cancer Enrolled on Clinical Trial NSABP-B-45 (NCT00914043) | NSABP Foundation Inc | |
| MRI in Women With Newly Diagnosed Breast Cancer Prior to Breast Conserving Surgery (NCT00695916) | Stanford University | |
| SU006668 in Treating Patients With Advanced Solid Tumors (NCT00024063) | Jonsson Comprehensive Cancer Center | |
| Study of Biomarkers in Tissue Samples From Patients With Breast Cancer (NCT01004796) | University of Wisconsin, Madison | |
| Epoetin Alfa in Treating Chemotherapy-Related Anemia in Women With Stage I, Stage II, or Stage III Breast Cancer (NCT00022386) | Jonsson Comprehensive Cancer Center | |
| TORI 104 Pre-Surgical Dasatinib (NCT01410708) | AHS Cancer Control Alberta | |
| High Risk Breast Cancer Screening Program (NCT00509509) | Organisation for Oncology and Translational Research | |
| Psychosocial Support in Treating Women With Recurrent Breast Cancer or Stage I, Stage II, or Stage IV Breast Cancer (NCT00416780) | Pittsburgh Mind-Body Center at Carnegie Mellon University | |
| Study of Alimta and Epirubicin Administered in Patients With Locally Advanced or Metastatic Breast Cancer (NCT00097383) | Eli Lilly and Company | |
| Acupuncture in Treating Hot Flashes in Women With Breast Cancer (NCT00081965) | Memorial Sloan Kettering Cancer Center | |
| 6 FEC 100 Vs 4 FEC 100 Followed by 4 Taxol in N+ Breast Cancer (NCT00189644) | Association Européenne de Recherche en Oncologie | |
| A Randomized, Placebo-Controlled Trial of BMS-275291 Given Daily for 12 Months to Women With Stage 1c-IIIA Breast Cancer Receiving Adjuvant Chemotherapy and/or Hormonal Therapy (NCT00036621) | Bristol-Myers Squibb | |
| An Investigational Drug (CAL) Versus Zoledronic Acid (Zometa®) in Patients With Breast Cancer (NCT00051779) | Chugai Pharma USA | |
| A Study of Cyclophosphamide/Methotrexate/5-Fluorouracil (CMF) With Pegfilgrastim in Subjects With Breast Cancer (NCT00124111) | Amgen | |
| Same Day Dosing of Pegfilgrastim in Breast Cancer Patients Undergoing Chemotherapy (TAC) (NCT00115414) | Amgen | |